Back
Vaxcyte Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
65
PCVX
Vaxcyte
Last Price:
69.19
Seasonality Move:
14.24%
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
127.16
Seasonality Move:
2.77%
Buy
65
Vaxcyte (PCVX)
is a Buy
Is Vaxcyte a Buy, Sell or Hold?
- The current Vaxcyte [PCVX] share price is $71.36. The Score for PCVX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PCVX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.30. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCVX Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
PCVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.49 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -606219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.84 - 71) | Buy |
| Bollinger Bands (100): | (62.2 - 73.06) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.27 | Buy |
| Relative Strength Index (14 RSI): | 47.13 | Sell |
| Chaikin Money Flow: | -440954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.72 - 134.4) | Sell |
| Bollinger Bands (100): | (114.96 - 132.98) | Buy |
PCVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.95 | Sell |
| 20-day SMA: | 67.18 | Buy |
| 50-day SMA: | 65.98 | Buy |
| 200-day SMA: | 59.41 | Buy |
| 8-day EMA: | 71.82 | Sell |
| 20-day EMA: | 68.77 | Buy |
| 50-day EMA: | 67.08 | Buy |
| 200-day EMA: | 60.62 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.15 | Sell |
| 20-day SMA: | 131.18 | Sell |
| 50-day SMA: | 126.79 | Buy |
| 200-day SMA: | 113.86 | Buy |
| 8-day EMA: | 130.54 | Sell |
| 20-day EMA: | 129.92 | Sell |
| 50-day EMA: | 127.19 | Buy |
| 200-day EMA: | 118.57 | Buy |
Vaxcyte Earnings Growth & PCVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $0.04 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
Vaxcyte Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||